The new pooled cohort equation tool requires further study with respect to its calibration and discrimination metrics. Pharmacotherapy of dyslipidemias linkedin slideshare. Dyslipidemia endocrine and metabolic disorders msd manual. Knowledge of pathophysiology of dyslipidemia has grown dramatically in.
Achievement of the lowdensity lipoprotein cholesterol goal among. Diagnosis is by measuring plasma levels of total cholesterol, tgs, and individual lipoproteins. The dyslipidemia clinical topic collection gathers the latest guidelines, news, jacc articles, education, meetings and clinical images pertaining to its cardiovascular topical area all in one place for your convenience. Dyslipidemia is recognized as a prominent risk factor for cardiovascular cv disease. Giri p, garg rk, singh mk, verma r, malhotra hs, sharma pk.
People with dyslipidemia canpeople with dyslipidemia can improve their lipid profiles by drinking cocoaimprove their lipid profiles by drinking cocoa 160 volunteers drank 10. Must be able to interpret data trends rather than data points. Prevalence of dyslipidemia in urban and rural india. Esceas guidelines for the management of dyslipidemias. Find powerpoint presentations and slides using the power of, find free presentations research about dyslipidemia management ppt. Guidlies for the diagnosis and management of dyslipidemia. View and download powerpoint presentations on dyslipidemia management ppt. Achieved ldl powerpoint is the worlds most popular presentation software which can let you create professional dyslipidemia and atherosclerosis powerpoint presentation easily and in no time. Dyslipidemia is divided up into primary and secondary types. Dyslipidemia and atherosclerosis powerpoint presentation. Case studies in the management of dyslipidemia by shana lettieri, pharmd, and tricia m. Apr 07, 2016 a read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext.
Free download powerpoint ppt presentation slides slidesfinder. Pharmacists in all practice settings can play a key role in screening individuals for dyslipidemia and overall cv risk. This is an open access article under the terms of the creative commons attribution. Classification examples of genetic diseases genetic defect. Expert opinion on the applicability of dyslipidemia. Slide set 2018 blood cholesterol guideline american. Dyslipidemia is a major risk factor for the development of atherosclerotic disease. See the 20 lifestyle management work group guideline for lifestyle recommendations for healthy adults. Sullivan fm, swan ir, donnan pt, et al 20 accaha guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults n engl j med.
Dyslipidemia from prevention to treatment intechopen. The image and slide gallery captures images, videos, or slides which can serve as useful teaching materials in the field of cv medicine. A recent analysis reaffirmed the importance of age in achieving threshold levels for treatment with the new model. Contemporary management and attainment of cholesterol targets.
Dyslipidemia current therapies guidelines usc journal. Worlds best powerpoint templates crystalgraphics offers more powerpoint templates than anyone else in the world, with over 4 million to choose from. Ischemic cardiovascular and cerebrovascular events are leading causes of morbidity and mortality. Dyslipidemia has a complex pathophysiology consisting of various genetic, lifestyle, and environmental factors. Achieved ldl download free article pdfs, sign up for alerts and more. All forms of ckd are included nondialysisdependent, dialysisdependent, and kidney transplant recipients. Determine a patients risk for coronary heart disease and treatment goals. Improving global outcomes kdigo organization developed a clinical practice guideline in 20 on lipid management and treatment of all adults and children with chronic kidney disease ckd. Updated guidelines for the management of dyslipidemia and. The accaha guidelines were last updated in 20, with several notable differences when compared to their prior iteration and to the 2011 esc eas guidelines. Aace protocol for standardized production of clinical practice guidelines, algorithms, and checklists 2017 update. Management of dyslipidemia in the elderly journal of. Health screening cohort nhisheals database from 2006 to 20.
Guidelines american association of clinical endocrinologists. Hypertension and dyslipidemia an ominous is the property of its rightful owner. Dyslipidemia is closely associated with atherosclerosis and is a major causal factor in the development of ischemic diseases. The uploader spent hisher valuable time to create this dyslipidemia and atherosclerosis powerpoint presentation slides, to share hisher useful content with the world. Ppt dyslipidemialipid management in diabetes powerpoint. Dyslipidemia is a major risk factor for atherosclerosis. Lipid effects of drug classes in dyslipidemia and hypertriglyceridemia. Russell, pharmd, bcps, cde pon successful completion of this continuing education activity, the pharmacist should be able to. Cardiovascular cv disease continues to be a significant cause of morbidity and mortalitycoronary disease and cerebrovascular disease are the second and third leading causes of death, respectively, in canada. Major dyslipidemia clinical practice guidelines approach primary prevention with the common aim of providing guidance on the optimal management of dyslipidemia. Because of the complications associated with dyslipidemia, it is vital that patients are provided with primary andor secondary prevention strategies to reduce the risk of cardiovascular disease cvd and protect highrisk patients from recurring events. Since then, considerable evidence, including randomized controlled trials of statin therapy in adults with ckd, has helped better define medical treatments for dyslipidemia. Clinical trials conclusively have demonstrated that treatment of lipid disorders can reduce chd morbidity and mortality. Atherosclerosis is a disease process that affects the coronary, cerebral and peripheral arterial circulation.
Coronary heart disease chd the etiology of atherosclerosis is multifactorial but the causeeffect relationship between dyslipidemia and. Requires highly motivatedinformed patients and healthcare support team. The journal of the american college of cardiology is published on behalf of the american college of cardiology foundation by elsevier inc circulation is published on behalf of the american heart association, inc. Jan 18, 2017 cardiovascular disease affects more than onethird of american adults and is the leading cause of mortality in the united states and worldwide. This helps you give your presentation on dyslipidemia and atherosclerosis in a conference, a school lecture, a business proposal, in a webinar and business and professional representations.
Dyslipidemia, specially high ldl cholesterol is the key risk factor for cardiovascular diseases. Classification examples of genetic diseases genetic. Significant ethnic differences exist due to the prevalence and types of lipid disorders. Theyll give your presentations a professional, memorable appearance the kind of sophisticated look that todays audiences expect. Methods phase i of the indian council of medical researchindia diabetes icmrindiab study was conducted in a representative population of three states of india tamil nadu, maharashtra and jharkhand and one union territory chandigarh, and covered a population of. Dyslipidemialipid management in diabetes is the property of its rightful owner. The national kidney foundationkidney disease outcomes quality initiative nkfkdoqi guideline for management of dyslipidemia in chronic kidney disease ckd was published in 2003. Identification and treatment of youth with dyslipidemia is of paramount.
Winner of the standing ovation award for best powerpoint templates from presentations magazine. Aim to study the pattern and prevalence of dyslipidemia in a large representative sample of four selected regions in india. Diagnosis and treatment of dyslipidemia new guidelines are based on the adult treatment plan iii atp iii 2004 focus multiple risk factor assessment to determine those individuals at highest absolute coronary heart disease chd risk diabetes is identified as being a chd risk equivalent in other words, a person with diabetes is considered at. Esc clinical practice guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on dyslipidaemias. Nov 10, 2018 the image and slide gallery captures images, videos, or slides which can serve as useful teaching materials in the field of cv medicine. In addition to undergoing a routine fasting lipid panel, individuals should also be screened for hypertension, diabetes. Dyslipidemia guidelines presentation v2 free download as powerpoint presentation. We examined the ldlc level among patients with dyslipidemia against. These guidelines are meant to update the 2005 clinical practice guidelines on the management of dyslipidemia in the philippines 2005 cpg. Dyslipidemia guidelines presentation v2 high density. Mar 14, 2014 the uploader spent hisher valuable time to create this dyslipidemia and atherosclerosis powerpoint presentation slides, to share hisher useful content with the world. This clinical practice guideline is intended for use only as a tool to assist a clinicianhealthcare professional and should not be used to replace clinical judgment. From the harrison school of pharmacy, auburn university, mobile, al.
The ccs screening recommendations, which can serve as a template for a focused patient history and clinical assessment, are summarized in table 1. Dyslipidemia is elevation of plasma cholesterol, triglycerides tgs, or both, or a low hdl cholesterol level that contributes to the development of atherosclerosis. The guideline is intended to improve patient outcomes and local management of patients with dyslipidemia. Ppt hypertension and dyslipidemia an ominous powerpoint. The strong link between dyslipidemia and the risk of future cardiovascular. This clinical practice guideline is a practical tool that endocrinologists, other health care professionals, healthrelated organizations, and regulatory bodies can use to reduce the risks and consequences of dyslipidemia. Treatment of lipid disorders also helps prevent stroke and peripheral arterial disease. It has many adverse health impacts, notably in the development of chronic noncommunicable diseases. Slide set 2018 blood cholesterol guideline american college of. The prevention of cardiovascular disease in adulthood begins with the diagnosis and treatment of dyslipidemia in childhood and adolescence. Practice guidelines for the management of dyslipidemia in the philippines 2015 cpg. Overview of clinical guidelines in lipid management. Give your memorable dyslipidemia and atherosclerosis presentation and build your crawd.
There is a clear linear relationship between the degree of ldlcholesterol lowering achieved with statins and benefits, with a 10% and 21% reduction in allcause mortality and major vascular events, respectively, per 1. Explore the latest in dyslipidemia, including recent guidelines for screening and use of statins, pcsk9 inhibitors, and other treatments. Treatment overview of dyslipidemia dyslipidemia is a powerful risk factor for coronary heart disease chd. View and download powerpoint presentations on dyslipidemia ppt. They should be essential in everyday clinical decision making. If so, share your ppt presentation slides online with. A panel of experts in the fields of dyslipidemia, cardiology, endocrinology and clinical epidemiology were assembled.
While elevated serum total and ldlcholesterol are the main concern in western populations. In a recent metaanalysis of 14 statin studies including. This is further supported by data showing superiority of more, compared to less, intensive ldlcholesterol lowering. The management of dyslipidemia for cardiovascular risk reduction lipids 2014 the management of dyslipidemia for cardiovascular risk reduction lipids 2014 update of cpg in progress. Update on screening, etiology, and treatment of dyslipidemia in. Sep 27, 2017 dyslipidemia is divided up into primary and secondary types. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Classification examples of genetic diseases frequency genetic defect common lipid abnormalities clinical findings type i chylomicronemia syndrome increased triglyceride levels and chylomicron particles lipoprotein lipase deficiency genetic defect of lpl gene autosomal recessive. Aggressive lowdensity lipoprotein ldlcholesterol lowering therapy, particularly statins, appear to be the most effective of the therapeutic approaches, but even with their use, cardiovascular disease event rates remain. Endorsed by the american association of cardiovascular and pulmonary rehabilitation, american pharmacists association, american society for preventive cardiology, association of black cardiologists, preventive cardiovascular nurses.
850 1104 807 1125 1244 279 347 170 280 189 625 177 525 1664 1484 1355 1505 850 1672 521 893 14 570 1349 57 312 1077 1024 1359 790 711 869 1111 1319 98 63 1478